异甘草酸镁与还原型谷胱甘肽治疗抗类风湿药物诱发的药物性肝损伤患者疗效比较

doi:10.3969/j.issn.1672-5069.2017.05.028

Abstract

Ruan Shengting, Xia Guangyun.. Application of glycyrrhizic acid magnesium and reduced glutathinone in treatment of patients with anti-rheumatoid arthritis-induced liver injuries[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 608-609.

References

[1] 温博，曾升平. 类风湿性关节炎的研究进展. 世界中西医结合杂志，2014，9（9）:1014-1019.
[2] 栗占国. 类风湿性关节炎. 北京:人民卫生出版社，2009:6.
[3] 赵学刚，刘晓敏，闫杰. 甘草酸二铵肠溶胶囊治疗类风湿性关节炎合并肝功能异常临床分析. 中国肝脏病杂志（电子版），2014，6（4）:12-13.
[4] 宋佳伟，邢蓉. 异甘草酸镁的药理与临床.中国新药与临床杂志，2012，31（10）:578-626.
[5] 金雯彦，于锋. 异甘草酸镁防治药物性肝损伤的药理及临床研究进展. 药学进展，2013，37（4）:161-166.
[6] 中华医学会风湿病学会分会. 类风湿性关节炎诊断及治疗指南. 中华风湿病学杂志，2010，14（4）:265-270.
[7] 王吉耀.现代肝病诊断与治疗. 上海:复旦大学出版社，2007:192-193.
[8] 王崇慧，郑三菊，占国清. 异甘草酸镁与复方甘草酸苷治疗慢性肝炎的疗效比较. 临床消化病杂志，2013，25（4）:203-205.
[9] 张亚兰，王建利，王静利，等. 免疫荧光法与免疫散射比浊法测定超敏C反应蛋白的相关性及其在感染中的重要意义.山西医药杂志，2015，44（20）:2360-2362.
[10] Fransen J，van Riel PL. The disease activity score and the EULAR response criteria.Clin Exp Rheumatol，2005，23（5 Suppl 39）:S93-99.
[11] 安缓，栗占国. 甲氨蝶呤和（或）来氟米特治疗类风湿性关节炎和银屑病关节炎肝损害发生情况的研究.中华风湿病学杂志，2010，14（2）:83-85.
[12] Curtis JR，Beukeleman T，Onofrei A，et al.Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with metheotrexate and/or leflunomide.Ann Rheum Dis，2010，69（6）:43-47.
[13] Lammert C，Bjonsson E，Niklasson A，et al. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events.Hepatology，2010，51（2）:615-620.
[14] 郭秀丽，姚士伟，张峻，等. 异甘草酸镁联合还原型谷胱甘肽治疗化疗药物性肝损伤临床疗效观察. 实用肝脏病杂志，2014，17（6）：575-578.
[15] 蒋彩虹，王小红，王煜.异甘草酸镁治疗慢性乙型肝炎疗效观察.药物与临床，2011，49（291）:69-70.

Application of glycyrrhizic acid magnesium and reduced glutathinone in treatment of patients with anti-rheumatoid arthritis-induced liver injuries

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.